Sotac Pharmaceuticals Board of Directors
Get the latest insights into the leadership at Sotac Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Sharadkumar Dashrathbhai Patel | Chairman & Managing Director |
| Mr. Dineshkumar Babulal Gelot | Whole Time Director |
| Mr. Vishalkumar Devrajbhai Patel | Executive Director |
| Mr. Chetankumar Bachubhai Patel | Executive Director |
| Mr. Ketankumar Arvindbhai Modi | Ind. Non-Executive Director |
| Mr. Bhavinkumar Prafulbhai Joshi | Ind. Non-Executive Director |
| Ms. Heena Viral Patel | Ind. Non-Executive Director |
Sotac Pharmaceuticals Share price
SOTAC
130.7
0.00 (0.00%)NSE
BSE
Last updated on 4 Sep, 2025 | 09:00 IST
BUYSELL
Today's High
00
Today's Low
00
52 Week Low
88.05
52 Week High
152.35
The current prices are delayed, login to your account for live prices
LoginSotac Pharmaceuticals FAQs
The board at Sotac Pharmaceuticals consists of experienced professionals, including Mr. Sharadkumar Dashrathbhai Patel , Mr. Dineshkumar Babulal Gelot , and others, overseeing the company’s strategic and corporate governance.
Directors at Sotac Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Sharadkumar Dashrathbhai Patel is the current chairman at Sotac Pharmaceuticals.
Executive directors at Sotac Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sotac Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sotac Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.